Acorda Therapeutics
$0.60289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.6028
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0031 (+0.52%) As of 10:04 AM EDT today
Why Robinhood?
You can buy or sell ACOR and other stocks, options, ETFs, and crypto commission-free!
About ACOR
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, and GGF2 (Cimaglermin alfa). Read More The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY. The listed name for ACOR is Acorda Therapeutics, Inc. Common Stock.
CEO
Employees
344
Headquarters
Ardsley, New York
Founded
1995
Market Cap
28.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
12.60M
High Today
$0.62
Low Today
$0.5525
Open Price
$0.565
Volume
1.31M
52 Week High
$3.10
52 Week Low
$0.4224
Collections
ACOR Earnings
-$1.06
-$0.56
-$0.05
$0.45
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 2, After Hours